Psychological and demographic characteristics of 368 patients with dissociative seizures: data from the CODES cohort.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
10 2021
Historique:
pubmed: 12 5 2020
medline: 27 1 2022
entrez: 12 5 2020
Statut: ppublish

Résumé

We examined demographic, clinical, and psychological characteristics of a large cohort (n = 368) of adults with dissociative seizures (DS) recruited to the CODES randomised controlled trial (RCT) and explored differences associated with age at onset of DS, gender, and DS semiology. Prior to randomisation within the CODES RCT, we collected demographic and clinical data on 368 participants. We assessed psychiatric comorbidity using the Mini-International Neuropsychiatric Interview (M.I.N.I.) and a screening measure of personality disorder and measured anxiety, depression, psychological distress, somatic symptom burden, emotional expression, functional impact of DS, avoidance behaviour, and quality of life. We undertook comparisons based on reported age at DS onset (<40 v. ⩾40), gender (male v. female), and DS semiology (predominantly hyperkinetic v. hypokinetic). Our cohort was predominantly female (72%) and characterised by high levels of socio-economic deprivation. Two-thirds had predominantly hyperkinetic DS. Of the total, 69% had ⩾1 comorbid M.I.N.I. diagnosis (median number = 2), with agoraphobia being the most common concurrent diagnosis. Clinical levels of distress were reported by 86% and characteristics associated with maladaptive personality traits by 60%. Moderate-to-severe functional impairment, high levels of somatic symptoms, and impaired quality of life were also reported. Women had a younger age at DS onset than men. Our study highlights the burden of psychopathology and socio-economic deprivation in a large, heterogeneous cohort of patients with DS. The lack of clear differences based on gender, DS semiology and age at onset suggests these factors do not add substantially to the heterogeneity of the cohort.

Sections du résumé

BACKGROUND
We examined demographic, clinical, and psychological characteristics of a large cohort (n = 368) of adults with dissociative seizures (DS) recruited to the CODES randomised controlled trial (RCT) and explored differences associated with age at onset of DS, gender, and DS semiology.
METHODS
Prior to randomisation within the CODES RCT, we collected demographic and clinical data on 368 participants. We assessed psychiatric comorbidity using the Mini-International Neuropsychiatric Interview (M.I.N.I.) and a screening measure of personality disorder and measured anxiety, depression, psychological distress, somatic symptom burden, emotional expression, functional impact of DS, avoidance behaviour, and quality of life. We undertook comparisons based on reported age at DS onset (<40 v. ⩾40), gender (male v. female), and DS semiology (predominantly hyperkinetic v. hypokinetic).
RESULTS
Our cohort was predominantly female (72%) and characterised by high levels of socio-economic deprivation. Two-thirds had predominantly hyperkinetic DS. Of the total, 69% had ⩾1 comorbid M.I.N.I. diagnosis (median number = 2), with agoraphobia being the most common concurrent diagnosis. Clinical levels of distress were reported by 86% and characteristics associated with maladaptive personality traits by 60%. Moderate-to-severe functional impairment, high levels of somatic symptoms, and impaired quality of life were also reported. Women had a younger age at DS onset than men.
CONCLUSIONS
Our study highlights the burden of psychopathology and socio-economic deprivation in a large, heterogeneous cohort of patients with DS. The lack of clear differences based on gender, DS semiology and age at onset suggests these factors do not add substantially to the heterogeneity of the cohort.

Identifiants

pubmed: 32389147
doi: 10.1017/S0033291720001051
pii: S0033291720001051
pmc: PMC8506352
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2433-2445

Subventions

Organisme : Department of Health
ID : 12/26/01
Pays : United Kingdom

Références

Epilepsia. 2003 Feb;44(2):236-42
pubmed: 12558580
Qual Life Res. 2009 Aug;18(6):727-35
pubmed: 19424821
Epilepsy Res. 2002 Feb;48(3):187-97
pubmed: 11904237
J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):761-2
pubmed: 22665451
Epilepsia. 2002 Feb;43(2):193-8
pubmed: 11903468
Seizure. 2014 Mar;23(3):222-6
pubmed: 24397968
Epilepsy Behav. 2006 May;8(3):649-50
pubmed: 16531122
Neurology. 2006 Jun 13;66(11):1644-7
pubmed: 16769934
Lancet Psychiatry. 2020 Jun;7(6):491-505
pubmed: 32445688
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Br J Psychiatry. 2002 May;180:461-4
pubmed: 11983645
Epilepsy Behav. 2013 Apr;27(1):1-3
pubmed: 23352998
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Trials. 2017 Jun 6;18(1):258
pubmed: 28587649
Epilepsy Behav. 2013 Jan;26(1):91-5
pubmed: 23247270
Epilepsia. 2019 Nov;60(11):2182-2193
pubmed: 31608436
Epilepsy Behav. 2018 Dec;89:130-134
pubmed: 30415134
Epilepsia. 2013 Nov;54(11):2005-18
pubmed: 24111933
J Neurol Neurosurg Psychiatry. 2006 May;77(5):616-21
pubmed: 16614021
Neurology. 1991 Oct;41(10):1643-6
pubmed: 1922808
J Psychosom Res. 2010 Mar;68(3):285-92
pubmed: 20159215
Eur J Health Econ. 2019 Mar;20(2):205-216
pubmed: 29445941
Epilepsy Behav. 2014 Apr;33:77-86
pubmed: 24632427
Seizure. 2013 Nov;22(9):760-5
pubmed: 23916276
Epilepsy Behav. 2015 May;46:60-5
pubmed: 25882323
Clin Psychol Rev. 2016 Apr;45:157-82
pubmed: 27084446
J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):295-301
pubmed: 24935983
Seizure. 2020 Jan;74:93-98
pubmed: 31869756
Epilepsy Behav. 2006 Dec;9(4):587-92
pubmed: 16997635
Neurology. 2010 Jan 5;74(1):64-9
pubmed: 20038774
Ann Neurol. 2003 Mar;53(3):305-11
pubmed: 12601698
J Neurol Neurosurg Psychiatry. 2011 Sep;82(9):967-9
pubmed: 21421771
Seizure. 1999 Feb;8(1):53-61
pubmed: 10091850
Neurology. 2002 Feb 12;58(3):493-5
pubmed: 11839862
Ann Neurol. 2011 Jun;69(6):997-1004
pubmed: 21437930
Cochrane Database Syst Rev. 2014 Feb 11;(2):CD006370
pubmed: 24519702
BMC Neurol. 2015 Jun 27;15:98
pubmed: 26111700
Epilepsia. 2008 Aug;49(8):1446-50
pubmed: 18410361
Seizure. 2005 Jan;14(1):33-9
pubmed: 15642498
Epilepsia Open. 2017 Jun 23;2(3):307-316
pubmed: 29588959
Epilepsy Behav. 2001 Dec;2(6):568-573
pubmed: 12609391
Seizure. 2000 Jul;9(5):314-22
pubmed: 10933985
Behav Cogn Psychother. 2018 Jan;46(1):84-100
pubmed: 28756794
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Epilepsy Behav. 2011 Feb;20(2):308-11
pubmed: 21195031
Seizure. 2000 Jun;9(4):280-1
pubmed: 10880289
Epilepsy Behav. 2018 Jan;78:161-165
pubmed: 29183659

Auteurs

Laura H Goldstein (LH)

King's College London, Institute of Psychiatry, Psychology and Neuroscience, UK.

Emily J Robinson (EJ)

King's College London, Institute of Psychiatry, Psychology and Neuroscience, UK.
King's College London, School of Population Health and Environmental Sciences, UK.

John D C Mellers (JDC)

South London and Maudsley NHS Foundation Trust, London, UK.

Jon Stone (J)

Centre for Clinical Brain Sciences, University of Edinburgh, UK.

Alan Carson (A)

Centre for Clinical Brain Sciences, University of Edinburgh, UK.

Trudie Chalder (T)

King's College London, Institute of Psychiatry, Psychology and Neuroscience, UK.

Markus Reuber (M)

Academic Neurology Unit, Royal Hallamshire Hospital, University of Sheffield, Sheffield, UK.

Carole Eastwood (C)

King's College London, Institute of Psychiatry, Psychology and Neuroscience, UK.

Sabine Landau (S)

King's College London, Institute of Psychiatry, Psychology and Neuroscience, UK.

Paul McCrone (P)

King's College London, Institute of Psychiatry, Psychology and Neuroscience, UK.

Michele Moore (M)

Centre for Social Justice and Global Responsibility, School of Law and Social Sciences, London South Bank University, London, UK.

Iris Mosweu (I)

King's College London, Institute of Psychiatry, Psychology and Neuroscience, UK.

Joanna Murray (J)

King's College London, Institute of Psychiatry, Psychology and Neuroscience, UK.

Iain Perdue (I)

King's College London, Institute of Psychiatry, Psychology and Neuroscience, UK.

Izabela Pilecka (I)

King's College London, Institute of Psychiatry, Psychology and Neuroscience, UK.

Mark P Richardson (MP)

King's College London, Institute of Psychiatry, Psychology and Neuroscience, UK.

Nick Medford (N)

South London and Maudsley NHS Foundation Trust, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH